|
V.B. Matveev, A.A. Kirichek, V.M. Safronova, K.O. Khafizov, M.G. Filippova, L.N. Lyubchenko
Impact of PD-L1 status on the long-term outcomes of radical treatment of patients with prostate cancer
|
№4 / 2019
|
|
A.V. Okishev, A.V. Govorov, A.O. Vasilyev, A.V. Bormotin, D.Y. Pushkar
Fusion biopsy of the prostate
|
№3 / 2019
|
|
O.Yu. Shestopalova, A.A. Jakovenko, A. Sh. Rumyantsev, А.V. Matveev, E.S. Nevirovich
A role of MRI-Ultrasound fusion targeted biopsy of prostate in the diagnosis of prostate cancer
|
№1 / 2019
|
|
A.N. Toropovsky, A.G. Nikitin, O.N. Pavlova, D.A. Viktorov
Perspectives of improvement of the diagnosis of prostate cancer based on analysis of PCA3 gene expression
|
№2 / 2019
|
|
O.V. Teodorovich, M.N. Shatokhin, S.A. Naryshkin, M.I. Abdullayev, A.V. Krasnov, G.G. Borisenko, A.A. Zhurbenko
Focal laser coagulation in the treatment of a patient with kidney cancer and prostate cancer
|
№2 / 2019
|
|
I.A. Aboyan, V.E. Aboyan, Yu.N. Orlov, S.M. Pakus, D.I. Pakus
Urodynamics study in patients with urinary incontinence, after surgical treatment of localized prostate cancer
|
№6 / 2018
|
|
I.I. Abdullin, F.A. Kossov, B.Sh. Kamolov, V.V. Kapustin, N.A. Grigor’ev, I.L. Gubskii, V.A. Chernyaev, V.O. Panov, Yu.V. Buidenok, V.B. Matveev
Use of multiparametric magnetic resonance imaging in t-staging of prostate cancer: a multicenter study
|
№4 / 2018
|
|
S.V. Popov, R.G. Guseinov, O.N. Skryabin, I.N. Orlov, A.G. Martov
Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy
|
№3 / 2018
|
|
M.V. Epifanova, M.E. Chalyi, B.R. Gvasaliya, I.I. Eremin, A.A. Pulin, I.I. Nadelyaeva, S.A. Artemenko, D.A. Galitskaya, A.M. Repin
New approaches for recovery of erectile function in patients after radical prostatectomy
|
№6 / 2017
|
|
A.V. Govorov, A.O. Vasilyev, A.A. Shiryaev, S.O. Sukhikh, A.V. Sidorenkov, A.V. Pushkarev, D.I. Tsiganov, D.Yu. Pushkar’
Current methods of early diagnosis of prostate cancer
|
№6 / 2017
|
|
A.V. Govorov, A.O. Vasil'ev, D.Yu. Pushkar
Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature
|
№6 (supplement) / 2016
|
|
A.O. Vasilyev, E.A. Prilepskaya, M.V. Kovylina, A.V. Govorov, A.V. Sadchenko, A.V. Sidorenkov, D.Yu. Pushkar
Contemporary markers and histological features of prostate cancer
|
№6 / 2016
|
Русский
